421
Views
8
CrossRef citations to date
0
Altmetric
Perspective

A theoretical framework and nomenclature to characterize the iatrogenic contribution of therapeutic opioid exposure to opioid induced hyperalgesia, physical dependence, and opioid use disorder

, , &
Pages 671-683 | Received 30 Aug 2019, Accepted 01 Jun 2020, Published online: 08 Sep 2020

References

  • Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an internet-based survey. J Pain: Off J Am Pain Soc. 2010;11:1230–39.doi:10.1016/j.jpain.2010.07.002.
  • Steglitz J, Buscemi J, Ferguson MJ. The future of pain research, education, and treatment: a summary of the IOM report “Relieving pain in America: a blueprint for transforming prevention, care, education, and research”. Transl Behav Med. 2012;2:6–8.doi:10.1007/s13142-012-0110-2.
  • Tanabe P, Buschmann M. a prospective study of ED pain management practices and the patient’s perspective. J Emerg Nurs. 1999;25:171–77.doi:10.1016/S0099-1767(99)70200-X.
  • KH T, Ducharme J, Choiniere M, CS C, DE F, Homel P, Tanabe P, PS G. Pain in the emergency department: results of the pain and emergency medicine initiative (PEMI) multicenter study. J Pain: Off J Am Pain Soc. 2007;8:460–66.doi:10.1016/j.jpain.2006.12.005.
  • Schappert SM, Rui PY, Ashman JJ, DeFrances CJ. Percentage of Emergency Department (ED) visits for pain* at which opioids(dagger) were given or prescribed, by patient age and year - national hospital ambulatory medical care survey, 2005-2016. Mmwr-Morbid Mortal W. 2018;67:1400–1400.
  • Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302:123.
  • Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25:171–86.doi:10.1016/0304-3959(86)90091-6.
  • Haddox JD, Joranson D, Angarola RT, Brady a, Carr DB, Blonsky ER, Burchiel K, Gitlin M, Midcap M, Payne R, et al. The use of opioids for the treatment of chronic pain. Clin J Pain. 1997;13:6–8.doi:10.1097/00002508-199703000-00003.
  • Lanser P, Gesell S. Pain management: the fifth vital sign. Healthc Benchmarks. 2001;8, 62:68–70.
  • Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;CD006605.
  • Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions in 2009. JAMA. 2011;305:1299–301.doi:10.1001/jama.2011.401.
  • Paulozzi LJ, Jones CM, Mack KA, Rudd RA. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008 (Reprinted from MMWR, vol 60, pg 1487-1492, 2011). Jama-J Am Med Assoc. 2011;306:2444–46.
  • Coffin P, Banta-Green C. The dueling obligations of opioid stewardship. Ann Intern Med. 2014;160:207.doi:10.7326/M13-2781.
  • Mazer-Amirshahi M, Mullins PM, Rasooly I, van den Anker J, Pines JM, Miner JR. Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010. Acad Emerg Med. 2014;21:236–43.doi:10.1111/acem.12328.
  • Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the united states, 2003-2013. JAMA. 2015;314:1468–78.doi:10.1001/jama.2015.11859.
  • Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in u.s. adults: 2015 national survey on drug use and health. Ann Intern Med. 2017;167:293.doi:10.7326/M17-0865.
  • Paulozzi LJ, Weisler RH, Patkar AA. a national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry. 2011;72:589–92.doi:10.4088/JCP.10com06560.
  • Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174:796.doi:10.1001/jamainternmed.2013.12711.
  • Rudd RA, Paulozzi LJ, Bauer MJ, Burleson RW, Carlson RE, Dao D, Davis JW, Dudek J, Eichler BA, Fernandes JC, et al. Centers for disease c, prevention. increases in heroin overdose deaths - 28 states, 2010 to 2012. MMWR Morb Mortal Wkly Rep. 2014;63:849–54.
  • Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. Jama. 2013;309:657–59.doi:10.1001/jama.2013.272.
  • Okie S. a flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363:1981–85.doi:10.1056/NEJMp1011512.
  • Dasgupta N, Kramer ED, Zalman MA, Carino S, Smith MY, Haddox JD, Wright C. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend. 2006;82:135–42.doi:10.1016/j.drugalcdep.2005.08.019.
  • Webster BS, Verma SK, Gatchel RJ. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine. 2007;32:2127–32.doi:10.1097/BRS.0b013e318145a731.
  • Manchikanti L, Therapeutic Opioids: SA. A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11:S63–S88.
  • Alam a, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery a retrospective cohort study. Arch Intern Med. 2012;172:425–30.doi:10.1001/archinternmed.2011.1827.
  • Olsen Y, Sharfstein JM. Chronic pain, addiction, and zohydro. N Engl J Med. 2014;370:2061–63.doi:10.1056/NEJMp1404181.
  • Butler MM, Ancona RM, Beauchamp GA, Yamin CK, Winstanley EL, Hart KW, Ruffner AH, Ryan SW, Ryan RJ, Lindsell CJ, et al. Emergency department prescription opioids as an initial exposure preceding addiction. Ann Emerg Med. 2016;68:202–08.doi:10.1016/j.annemergmed.2015.11.033.
  • Barnett ML, Olenksi AR, Jena AB. Opioid prescribing by emergency physicians and risk of long-term use. N Engl J Med. 2017;376:1896.doi:10.1056/NEJMsa1610524.
  • Shah a, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66:265–69.doi:10.15585/mmwr.mm6610a1.
  • Shah a, Hayes CJ, Martin BC. Factors influencing long-term opioid use among opioid naive patients: an examination of initial prescription characteristics and pain etiologies. J Pain: Off J Am Pain Soc. 2017;18:1374–83.doi:10.1016/j.jpain.2017.06.010.
  • Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am J Public Health. 2014;104:2023–29.doi:10.2105/AJPH.2014.302147.
  • Perrone J, Mycyk MB, Cone DC. a challenging crossroad for emergency medicine: the epidemics of pain and pain medication deaths. Acad Emerg Med. 2014;21:334–36.doi:10.1111/acem.12323.
  • Nelson LS, Juurlink DN, Perrone J. Addressing the Opioid Epidemic. JAMA. 2015;314:1453–54.doi:10.1001/jama.2015.12397.
  • Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ. 2014;348:g1251.doi:10.1136/bmj.g1251.
  • Hoppe JA, Kim H, Heard K. Association of emergency department opioid initiation with recurrent opioid use. Ann Emerg Med. 2015;65:493–499 e494.doi:10.1016/j.annemergmed.2014.11.015.
  • Barnett ML, Olenski AR, Jena AB. Opioid-prescribing patterns of emergency physicians and risk of long-term use. N Engl J Med. 2017;376:663–73.
  • Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007;129:235–55.doi:10.1016/j.pain.2007.03.028.
  • Ballantyne JC, Kolodny a. Preventing prescription opioid abuse. JAMA. 2015;313:1059.doi:10.1001/jama.2015.0521.
  • Cheatle MD. Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities. Expert Rev Clin Pharmacol. 2016;9:751–54.doi:10.1586/17512433.2016.1160776.
  • Brat GA, Agniel D, Beam a, Yorkgitis B, Bicket M, Homer M, Fox KP, Knecht DB, McMahill-Walraven CN, Palmer N, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790.doi:10.1136/bmj.j5790.
  • Delgado MK, Huang Y, Meisel Z, Hennessy S, Yokell M, Polsky D, Perrone J. National variation in opioid prescribing and risk of prolonged use for opioid-naive patients treated in the emergency department for ankle sprains. Ann Emerg Med. 2018;72:389–400 e381.doi:10.1016/j.annemergmed.2018.06.003.
  • Jeffery MM, Hooten WM, Hess EP, Meara ER, Ross JS, Henk HJ, Borgundvaag B, Shah ND, Bellolio MF. Opioid prescribing for opioid-naive patients in emergency departments and other settings: characteristics of prescriptions and association with long-term use. Ann Emerg Med. 2017.
  • Rayport M. Experience in the management of patients medically addicted to narcotics. J Am Med Assoc. 1954;156:684–91.doi:10.1001/jama.1954.02950070012004.
  • Bailey JA, Hurley RW, Gold MS. Crossroads of pain and addiction. Pain Med. 2010;11:1803–18.doi:10.1111/j.1526-4637.2010.00982.x.
  • Von Korff MR, Franklin G. Responding to America’s Iatrogenic epidemic of prescription opioid addiction and overdose. Med Care. 2016;54:426–29.doi:10.1097/MLR.0000000000000537.
  • Meier B The Delicate Balance Of Pain and Addiction. In New York Times, 2003.
  • Catan T, Evan P. A pain-drug champion has second thoughts. WSJ. 2012.
  • Peppin JF, Cheatle MD, Kirsh KL, McCarberg BH. The complexity model: a novel approach to improve chronic pain care. Pain Med. 2015;16:653–66.doi:10.1111/pme.12621.
  • Comer SD, Sullivan MA, Vosburg SK, Kowalczyk WJ, Houser J. Abuse liability of oxycodone as a function of pain and drug use history. Drug Alcohol Depend. 2010;109:130–38.doi:10.1016/j.drugalcdep.2009.12.018.
  • Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002;1:13–20.doi:10.1151/spp021113.
  • Nelson LS, Paulozzi LJ. The toxicology tower of Babel: why we need to agree on a lexicon in prescription opioid research. J Med Toxicol. 2012;8:331–32.doi:10.1007/s13181-012-0266-7.
  • Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Degroot a, Edwards RR, Haddox JD, Jaffe JH, et al. Addiction clinical trials TIO, networks public-private p. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154:2287–96.doi:10.1016/j.pain.2013.05.053.
  • Broyles LM, Binswanger IA, Jenkins JA, Finnell DS, Faseru B, Cavaiola a, Pugatch M, Gordon AJ. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abuse. 2014;35:217–21.doi:10.1080/08897077.2014.930372.
  • Inc.; T, Center for Substance Abuse Treatment (CSAT) SAaMHSAS. Substance use disorders: a guide to the use of language. Rockville, MD, 2004.
  • Crofford LJ. Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol. 2010;6:191–97.doi:10.1038/nrrheum.2010.24.
  • Edlund MJ, Martin BC, Russo JE, DeVries a, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30:557–64.doi:10.1097/AJP.0000000000000021.
  • Jordan CJ, Andersen SL. Sensitive periods of substance abuse: early risk for the transition to dependence. Dev Cogn Neurosci. 2017;25:29–44.doi:10.1016/j.dcn.2016.10.004.
  • Voon P, Kerr T. “Nonmedical” prescription opioid use in North America: a call for priority action. Subst Abuse Treat Pr. 2013;8.
  • Garland EL. Treating chronic pain: the need for non-opioid options. Expert Rev Clin Pharmacol. 2014;7:545–50.doi:10.1586/17512433.2014.928587.
  • Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep. 2016;65:1–49.doi:10.15585/mmwr.rr6501e1.
  • O’Brien CP, Volkow N, Li TK. What’s in a word? Addiction versus dependence in DSM-V. Am J Psychiatry. 2006;163:764–65.doi:10.1176/ajp.2006.163.5.764.
  • Clark MR, Hurley RW, Adams MCB. Re-assessing the validity of the opioid risk tool in a tertiary academic pain management center population. Pain Med. 2018.doi:10.1093/pm/pnx332.
  • Varney SM, Perez CA, Arana AA, Carey KR, Ganem VJ, Zarzabal LA, Ramos RG, Bebarta VS. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and opioid assessment for patients with pain-revised (SOAPP((R))-R), current opioid misuse measure (COMM), and provider gestalt. Intern Emerg Med. 2018;13:1239–47.doi:10.1007/s11739-018-1804-3.
  • Arout CA, Edens E, Petrakis IL, Sofuoglu M. Targeting opioid-induced hyperalgesia in clinical treatment: neurobiological considerations. CNS Drugs. 2015;29:465–86.doi:10.1007/s40263-015-0255-x.
  • Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. a comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14:145–61.
  • Silverman SM. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician. 2009;12:679–84.
  • Yaksh TL, Harty GJ, Onofrio BM. High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology. 1986;64:590–97.doi:10.1097/00000542-198605000-00008.
  • Swartjes M, Mooren RA, Waxman AR, Arout C, van de Wetering K, den Hartigh J, Beijnen JH, Kest B, Dahan a. Morphine induces hyperalgesia without involvement of mu-opioid receptor or morphine-3-glucuronide. Mol Med. 2012;18:1320–26.doi:10.2119/molmed.2012.00244.
  • Juni a, Klein G, Kest B. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res. 2006;1070:35–44.doi:10.1016/j.brainres.2005.11.054.
  • Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, Slivka PF, Coats BD, Rezvani N, Wieseler J, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 2010;24:83–95.doi:10.1016/j.bbi.2009.08.004.
  • Webster LR. Risk factors for opioid-use disorder and overdose. Anesth Analg. 2017;125:1741–48.doi:10.1213/ANE.0000000000002496.
  • Daum AM, Berkowitz O, Renner JA Jr. The evolution of chronic opioid therapy and recognizing addiction. JAAPA. 2015;28:23–27.doi:10.1097/01.JAA.0000464268.60257.ad.
  • Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? a structured evidence-based review. Pain Med. 2008;9:444–59.doi:10.1111/j.1526-4637.2007.00370.x.
  • Martell BA, O’Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146:116–27.doi:10.7326/0003-4819-146-2-200701160-00006.
  • Martins SS, Keyes KM, Storr CL, Zhu H, Chilcoat HD. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend. 2009;103:16–24.doi:10.1016/j.drugalcdep.2009.01.019.
  • Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS, Stewart WF. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105:1776–82.doi:10.1111/j.1360-0443.2010.03052.x.
  • Coluzzi F, Pappagallo M. National Initiative on Pain C. Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy. Minerva Anestesiol. 2005;71:425–33.
  • Leonardi C, Vellucci R, Mammucari M, Fanelli G. Opioid risk addiction in the management of chronic pain in primary care: the addition risk questionnaire. Eur Rev Med Pharmacol Sci. 2015;19:4898–905.
  • Drewes AM, Jensen RD, Nielsen LM, Droney J, Christrup LL, Arendt-Nielsen L, Riley J, Dahan a. Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol. 2013;75:60–78.doi:10.1111/j.1365-2125.2012.04317.x.
  • Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84:613–24.doi:10.1016/S0025-6196(11)60750-7.
  • Somogyi AA, Barratt DT, Coller JK. Pharmacogenetics of opioids. Clin Pharmacol Ther. 2007;81:429–44.doi:10.1038/sj.clpt.6100095.
  • Pasternak GW. Molecular biology of opioid analgesia. J Pain Symptom Manage. 2005;29:S2–9.doi:10.1016/j.jpainsymman.2005.01.011.
  • Bieber CM, Fernandez K, Borsook D, Brennan MJ, Butler SF, Jamison RN, Osgood E, Sharpe-Potter J, Thomson HN, Weiss RD, et al. Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Exp Clin Psychopharmacol. 2008;16:429–34.doi:10.1037/1064-1297.16.5.429.
  • Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician. 2008;11:S105–120.
  • Evans CJ, Cahill CM. Neurobiology of opioid dependence in creating addiction vulnerability. F1000Res. 2016;5.doi:10.12688/f1000research.8369.1.
  • Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15:ES67–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.